Mission
THE GATES MRI ENGAGES DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-AND LOWER-MIDDLE-INCOME COUNTRIES.
Public Charity
GATES MEDICAL RESEARCH INSTITUTE
GATES MEDICAL RESEARCH INSTITUTE is a Public Charity headquartered in CAMBRIDGE, MA. Financial data from the 2024 filing: $132.8M revenue, $341.1M expenses, $613.2M total assets. 12 publicly reported grants to this organization, totaling roughly $18.3M, appear in IRS filings.
EIN: 821808476
CAMBRIDGE, MA
Research Institutes & Public Policy Analysis
NTEE: E05
Latest filing: 2024
Total Revenue$132.8M
Total Expenses$341.1M
Total Assets$613.2M
Grant Records12
Funding Total$18.3M
Filing Years2019–2024
Where $100 goes at Gates Medical Research Institute
How Gates Medical Research Institute divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
$90
Programs
the work itself
$10
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $90 for programs
$57
The gates mri's largest program area focuses on reducing the burden of tuberculosis through the research and development of novel therapeutics and vaccine candidates, including through the conduct…
$33
Gates Medical Research Institute ("gates mri") is aligned with the purpose of the gates foundation and guided by the vision that every person deserves the opportunity to lead…
Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
For grant recipient's exempt purposes
$6,790
For grant recipient's exempt purposes
$6,790
COVID-19 THERAPEUTICS
$18,000,000
Unrestricted
$26,764
For grant recipient's exempt purposes
$17,527
Showing up to 5 of 12 total records — full history available with membership.
Officers & Directors
HEAD OF DEVELOPMENT
Alexander Schmidt
DIRECTOR
Carolyn Ainslie
HEAD OF THERAPEUTICS DEVELOPMENT
Charles Wells
HEAD OF CORP STRAT & MKT ACCESS
Claire Wagner
CHIEF OPERATING OFFICER
Debra Weiss
CHIEF EXECUTIVE OFFICER (END 6/24)
Emilio Emini
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $132.8M | $341.1M | $613.2M |
| 2023 | $809.5M | $189.6M | $817.0M |
| 2022 | $12.3M | $137.2M | $186.5M |
| 2020 | $32.1M | $99.4M | $171.4M |
| 2019 | $9.8M | $41.2M | $219.3M |
Between 2019 and 2024, reported annual revenue grew from $9.8M to $132.8M (+1254%), with total assets most recently reported at $613.2M.
Interactive year-over-year charts and full filing details available with membership.